Assessment of Adherence to Iron Chelation Therapy Among Thalassemia Patients in Palestine.

ABSTRACT:

Background

Beta-thalassemia major (β-TM) is a severe hereditary blood disorder, common in Palestine due to high consanguinity rates. Lifelong iron chelation therapy (ICT) is vital for managing iron overload from regular transfusions, but adherence remains a major challenge.

Objective

This study investigates factors influencing ICT adherence among β-TM patients in Palestine, focusing on sociodemographic, clinical, psychological, and healthcare-related aspects.

Methods

A cross-sectional study was conducted at the National Thalassemia Center, Nablus, from July 2024 to the end of October 2024, including 120 β-TM patients aged 3-33. Data were collected through structured interviews using a validated questionnaire covering demographics, disease knowledge, adherence, and sat

SUBMITTER: Zabadi HA 

PROVIDER: S-EPMC12663867 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature